scispace - formally typeset
G

Giorgio Roma

Researcher at University of Genoa

Publications -  78
Citations -  1551

Giorgio Roma is an academic researcher from University of Genoa. The author has contributed to research in topics: Pyran & Bicyclic molecule. The author has an hindex of 20, co-authored 78 publications receiving 1485 citations.

Papers
More filters
Journal ArticleDOI

1,8-Naphthyridines IV. 9-Substituted N,N-dialkyl-5-(alkylamino or cycloalkylamino) [1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides, new compounds with anti-aggressive and potent anti-inflammatory activities

TL;DR: Several compounds 8 exhibited high anti-inflammatory activity (carrageenin-induced paw edema assay in the rat) along with appreciable anti-aggressive properties (isolation-induced aggressiveness test in mice) and the structure-activity relationships are discussed.
Journal ArticleDOI

1,5-Benzodiazepines. Part XII. Synthesis and biological evaluation of tricyclic and tetracyclic 1,5-benzodiazepine derivatives as nevirapine analogues.

TL;DR: The modifications introduced into nevirapine heterocyclic skeleton proved to have a negative effect for the anti-HIV-1 activity and some of the new derivatives proved to be cytotoxic in the low micromolar range.
Journal ArticleDOI

1,5-Benzodiazepines: Part XIII. Substituted 4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines and 4H-imidazo[1,2-a][1,5]benzodiazepin-5-amines as analgesic, anti-inflammatory and/or antipyretic agents with low acute toxicity

TL;DR: The 5-(dibutylamino) derivatives 5b and 5f proved to be significantly endowed with all these activities and almost all the compounds 3, 4 and 5 did not show acute toxicity in mice up to 800 mg kg(-1) os dose.
Journal ArticleDOI

Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis

TL;DR: In order to consider also the 4-aminocoumarin structural class, a new statistically significant 3-D QSAR model is developed based on the antiplatelet activity data and molecular steric and electrostatic potentials of both the previously studied and herein described compounds.